JAGSONPAL PHARMACEUTICALS LTD. - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)

We wish to inform you that consequent to the appointment of Mr. Ashish Lakhotia, Chief Financial Officer of the Company, the Board of Directors have approved the Change in KMPs for authorised for the purpose of the determining the event or information for making the disclosure under SEBI LODR.